Activation of human platelets by platelet activating factor (PAF) derived from sensitized rabbit basophils
- PMID: 738767
- PMCID: PMC1457439
Activation of human platelets by platelet activating factor (PAF) derived from sensitized rabbit basophils
Abstract
Rabbit basophil-derived platelet activating factor (PAF), a mediator of anaphylaxis, induces the aggregation and release of serotonin from rabbit platelets. In the present study, we report that PAF obtained by challenge of specifically sensitized rabbit basophils induced the noncytotoxic release of serotonin from human platelets; maximal extent of release ranged between 34-46%. This release was unaltered in the presence of indomethacin, indicating that such secretion was not a consequence of contaminating arachidonic acid; further, as previously demonstrated with platelets of rabbit origin, it was markedly independent of a requirement for an intact prostaglandin biosynthetic pathway. In contrast to its effect upon rabbit platelets, rabbit PAF did not induce aggregation of human platelets, suggesting that the aggregation and secretion reactions induced by this agent are separable and that this cross-species activation may be incomplete. Whether this is a result of the differential ability of rabbit PAF to bind to and activate rabbit as compared to human platelets or to the existence of a family of PAF molecules is not yet known. The capacity of PAF to participate in a secretory event involving human platelets lends support to the belief that PAF may play an important ubiquitous role in the cooperative, leucocyte-dependent, release of vasoactive amines which results in increased vascular permeability.
Similar articles
-
Activation of rabbit platelets by platelet-activating factor derived from IgE-sensitized basophils. Characteristics of the aggregation and its dissociation from secretion.J Clin Invest. 1977 Aug;60(2):481-90. doi: 10.1172/JCI108799. J Clin Invest. 1977. PMID: 874106 Free PMC article.
-
Platelet activating factor (PAF). A possible direct mediator of anaphylaxis in the rabbit and a trigger for the vascular deposition of circulating immune complexes.Monogr Allergy. 1977;12:13-26. Monogr Allergy. 1977. PMID: 335211 Review.
-
Release of platelet-activating factor in human pathology. I. Evidence for the occurrence of basophil degranulation and release of platelet-activating factor in systemic lupus erythematosus.Lab Invest. 1981 Mar;44(3):241-51. Lab Invest. 1981. PMID: 7464048
-
Immunological mechanisms of human platelet involvement.Ric Clin Lab. 1978 Oct-Dec;8(4):262-72. Ric Clin Lab. 1978. PMID: 734319
-
Forty Years Since the Structural Elucidation of Platelet-Activating Factor (PAF): Historical, Current, and Future Research Perspectives.Molecules. 2019 Dec 3;24(23):4414. doi: 10.3390/molecules24234414. Molecules. 2019. PMID: 31816871 Free PMC article. Review.
Cited by
-
Platelet activating factor: an inhibitor of neutrophil activation?Clin Exp Immunol. 1981 Jan;43(1):135-42. Clin Exp Immunol. 1981. PMID: 7249391 Free PMC article.
-
Human platelet stimulation by acetyl glyceryl ether phosphorylcholine.J Clin Invest. 1981 Mar;67(3):903-6. doi: 10.1172/jci110108. J Clin Invest. 1981. PMID: 7204562 Free PMC article.
-
Platelet-Activating Factor Promotes the Development of Non-Alcoholic Fatty Liver Disease.Diabetes Metab Syndr Obes. 2022 Jul 8;15:2003-2030. doi: 10.2147/DMSO.S367483. eCollection 2022. Diabetes Metab Syndr Obes. 2022. PMID: 35837578 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources